Skip to main content
SpringerLink
Log in

Pankreaskarzinom

  • Chapter
Book cover Therapiekonzepte Onkologie

  • 67 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Wingo P, Tong T, Bolden S (1995) statistics 1995. CA Cancer J Clin 45:8–30

    Article  PubMed  CAS  Google Scholar 

  2. Evans D, Abbruzzese J, Rich T (1997) Cancer of the pancreas. In DeVita V, Hellman S, Rosenberg S (eds) Cancer-principles and practice of oncology. J.B. Lippincott 5thedition: 1054–1087

    Google Scholar 

  3. Niederhuber J, Brennan M, Menck H (1995) The national cancer data base report on pancreatic cancer. Cancer 76:1671–1677

    Article  PubMed  CAS  Google Scholar 

  4. Ahlgren J (1996) Epidemiology and risk factors in pancreatic cancer. Semin Oncol 23:241–250

    PubMed  CAS  Google Scholar 

  5. Murr M, Sarr M, Oishi A, van Heerden J (1994) Pancreatic cancer. CA Cancer J Clin 44:304–318

    Article  PubMed  CAS  Google Scholar 

  6. TNM-Klassifikation maligner Tumoren, 5. Auflage (1997) In: Wittekind Ch, Wagner G (Hrsg), Springer-Verlag

    Google Scholar 

  7. Konsensuskonferenz (1996) Leitlinien zur Therapie des exokrinen Pankreaskarzioms. Onkologie 1996; 19:516–519

    Article  Google Scholar 

  8. Douglass A (1995) Adjuvant Therapy for Pancreatic Cancer. World J Surg 19:270–274

    Article  PubMed  Google Scholar 

  9. Thomas P (1996) Radiotherapy for carcinoma of the pancreas. Semin Oncol 23:213–219

    PubMed  CAS  Google Scholar 

  10. Spitz FR, Abbruzzese JL, Lee JE et al. (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928–937

    PubMed  CAS  Google Scholar 

  11. Hoffmann JP, Weese JL, Solin LJ et al. (1995) Preoperative chemoradiation for patients with resectable pancreatic adenocarcinoma: An Eastern Cooperative Oncology Study Group (ECOG) phase II study. Proc Am Soc Clin Oncol 14:201 (abstract)

    Google Scholar 

  12. Staley CA, Lee JE, Cleary KA et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreas head. Am J Surg 171:118–125

    Article  PubMed  CAS  Google Scholar 

  13. Kaiser MH, Ellenberg SS (1985) Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903

    Article  Google Scholar 

  14. Yeo CJ, Cameron JL, Lillemoe KD et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221:721–731

    Article  PubMed  CAS  Google Scholar 

  15. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006–2010

    Article  Google Scholar 

  16. Whittington R, Bryer MP, Haller DG et al. (1991) Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21:1137–1143

    Article  PubMed  CAS  Google Scholar 

  17. Foo ML, Gunderson LL, Nagorney DM et al. (1993) Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/-5-fluorouracil. Int J Radiat Oncol Biol Phys 26:483–489

    Article  PubMed  CAS  Google Scholar 

  18. Moertel C, Childs D, Reitermeier R et al. (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865–867

    Article  PubMed  CAS  Google Scholar 

  19. Moertel C, Frytak S, Hahn R et al. (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate doseradiation (4000 rads + 5-fluorouracil) and high dose radiation + fluorouracil. Cancer 48:1705–1710

    Article  PubMed  CAS  Google Scholar 

  20. Gastrointestinal Tumor study Group (1985) Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 56:2563–2568

    Article  Google Scholar 

  21. Klaasen D, MacIntyre J, Catton G et al. (1985) Treatment of locally unresecable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil. An Eastern Cooperative Group Study. J Clin Oncol 3:373–378

    Google Scholar 

  22. Gastrointestinal Tumor Study Group (1988) Treatment of locally unresectable carcinoma of the pancreas: comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80:751–755

    Article  Google Scholar 

  23. Seydel H, Stablein D, Leichman L et al. (1990) Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. Cancer 65:1478–1482

    Article  PubMed  CAS  Google Scholar 

  24. Treurniet-Donker A, van Mierlo M, van Putten V et al. (1990) Localized unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 18:59–62

    Article  PubMed  CAS  Google Scholar 

  25. Boz G, Paoli A, Roncadin M et al. (1991) Radiation therapy combined with chemotherapy for inoperable pancreatic carcinoma. Tumore 77:61–64

    CAS  Google Scholar 

  26. Picus J, Dickerson G, Logie K et al. (1994) A phase II study of unresectable pancreatic cancer treated with 5-FU and leucovorin with radiation therapy: A Hoosier Oncology Group Study. Proc Am Soc Clin Oncol 13:208 (# 620)

    Google Scholar 

  27. Moertel C, Gunderson L, Lailliard J et al. (1994) Early evaluation of combined fluorouracil and leucovorin in unresectable, residual, or recurrent gastrointestinal carcinoma. J Clin Oncol 12:21–27

    PubMed  CAS  Google Scholar 

  28. Nguyen T, Theobald S, Rougier P et al. (1997) Multicentric pilot study of simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-meta-stastic adenocarcinoma of the pancreas. Proc Am Soc Clin Oncol 16:299 a (#1067)

    Google Scholar 

  29. Terk M, Turhal N, Mandeli J (1997) Long-term follow-up of combined modality therapy for unresectable pancreatic cancer. Proc Am Soc Clin Oncol 16:307 a (#1094)

    Google Scholar 

  30. Prott F, Schonekaes K, Preusser P et al. (1997) Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. Br J Cancer 75: 597–601

    Article  PubMed  CAS  Google Scholar 

  31. Andre T, Balosso J, Louvet C et al. (1997) Does chemoradiotherapy (CRT) allow resection of initially unresectable pancreatic adenocarcinoma (UPA)? Proc Am Soc Clin Oncol 16:281a (#997)

    Google Scholar 

  32. Coia L, Hoffman J, Scher R et al. (1994) Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 30:161–167

    Article  PubMed  CAS  Google Scholar 

  33. Tepper JE, Noves D, Krall JM et al. (1991) Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Int J Radiat Oncol Biol Phys 21:1145–1152

    Article  PubMed  CAS  Google Scholar 

  34. Roldan GE, Gunderson LL, Nagorney DM et al. (1988) External beam vs intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61:1110–1116

    Article  PubMed  CAS  Google Scholar 

  35. Tuckson WB, Goldson AL, Ashayeri E, Halyard-Richarson M, Dewitty RL, Leffall LD (1988) Intraoperative radiotherapy for patients with carcinoma of the pancreas. The Howard University Hospital experience 1978–1986. Ann Surg 207:648–652

    Article  PubMed  CAS  Google Scholar 

  36. Mohiuddin M, Regine WF, Stevens J et al. (1995) Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 13:2764–2771

    PubMed  CAS  Google Scholar 

  37. Lionetto R, Pugliese V, Bruzzi P, Rosso R (1995) No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 31A:882–887

    Article  PubMed  CAS  Google Scholar 

  38. Rougier P, De Forin M, Ademis A et al. (1994) Phase II study of taxotere (RP 56976, docetaxel) in pancreatic adenocarcinoma (PAC). Proc Am Soc Clin Oncol 13:200 (# 587)

    Google Scholar 

  39. Abbruzzese I, Evans D, Gravel D et al. (1995) Docetaxel (D) a potentially active agent for patients with pancreatic adenocarcinoma (PA). Proc Am Soc Clin Oncol 14:221 (#561)

    Google Scholar 

  40. Mallinson CN, Rake MO, Cocking JB et al. (1980) Chemotherapy in pancreatic cancer: results of a controlled, randomised, multicentre trial. Br Med J 281: 1589–1591

    Article  PubMed  CAS  Google Scholar 

  41. Frey C, Twomey P, Kheen R et al. (1981) Randomized study of 5-fluorouracil and CCNU in pancreatic cancer. Cancer 47:27–31

    Article  PubMed  CAS  Google Scholar 

  42. Andersen J, Friis-Moller A, Hancke S et al. (1981) A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer. Scand J Gastroenterol 16:973–975

    Article  PubMed  CAS  Google Scholar 

  43. Andren-Sandberg A, Holmberg J, Ihse I (1983) Treatment of unresectable pancreatic carcinoma with 5-fluorouracil, vincristine, and CCNU. Scand J Gastroenterol 18:609–612

    Article  PubMed  CAS  Google Scholar 

  44. Palmer K, Kerr M, Knowles G, Cull A, Carter D, Leonard R (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81:882–885

    Article  PubMed  CAS  Google Scholar 

  45. Glimelius B, Hoffmann K, Sjöden P-O, Jacobsson G, Seilström H, Eander L-K, Linne T, Svensson C (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593–600

    Article  PubMed  CAS  Google Scholar 

  46. Nicolson M, Webb A, Cunningham D, Norman A, O’Brian M, Hill A, Hickish T (1995) Cisplatin and protraced infusion 5-fluorouracil (CF) — good symptom relief with low toxicity in advanced pancreatic carcinoma. Ann Oncol 6:801–804

    Google Scholar 

  47. Rothenberg ML, Moore MJ, Cripps MC, Andersen LS, Portenoy RK, Burris HA, Green MR, Tarasoff PG, Brown TD, Casper ES, Storniolo A-M, Von Hoff DD (1996) A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 7:347–353

    Article  PubMed  CAS  Google Scholar 

  48. Andre T, Lotz JP, Boulec J et al. (1996) Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. Ann Oncol 7: 173–178

    Article  PubMed  CAS  Google Scholar 

  49. Raymond E, Louvet C, De Gramount A, Beerblock K, Tournigand C, Varette C, Demuynck B, Krulik M (1996) Clinical benefit (CB) improvment with hydroxyurea (HU), leucovorin (LV), 5FU and Cisplatin (HLEP regimen) in advanced pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 15:212 (abstr. 489)

    Google Scholar 

  50. Storniolo A, Enas N, Brown C et al. (1997) Treatment investigational new drug program for Gemzar®(gemcitabine HCL) in patients with pancreas cancer (PaCa). Proc Am Soc Clin Oncol 16:306a (#1088)

    Google Scholar 

  51. Burris III H, Moore M, Andersen J et al. (1997) Improvments in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. Kollmannsberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kollmannsberger, C., Fink, U. (1998). Pankreaskarzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10493-4_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63821-6

  • Online ISBN: 978-3-662-10493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation